Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group

Haruyasu Murakami, Takeharu Yamanaka, Takashi Seto, Kenji Sugio, Isamu Okamoto, Toshiyuki Sawa, Tomonori Hirashima, Koji Takeda, Shinji Atagi, Masahiro Fukuoka, Yoichi Nakanishi, Kazuhiko Nakagawa, Nobuyuki Yamamoto

Research output: Contribution to journalArticle

14 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences